FDA Drug Safety Initiative Will Include New Website On Rx Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
The site is intended as an avenue for the agency to disclose safety issues that have not yet been definitively reviewed, and to emphasize the risks with all prescription drugs. The website proposal is understood to be in the internal agency review phase.
You may also be interested in...
“Drug Watch” Website Included In FDA’s Rx Safety Reforms
FDA will launch a Drug Watch website as part of its drug safety reform initiative
“Drug Watch” Website Included In FDA’s Rx Safety Reforms
FDA will launch a Drug Watch website as part of its drug safety reform initiative
U.K. Adverse Events System Will Allow Patients To Submit Reports, Review Data
The Medicines & Healthcare Products Regulatory Agency will have a final system for direct patient reporting of adverse events by 2006, the agency says. MHRA seems to acknowledge the careful balance required to post adverse event data without deterring appropriate drug use.